- About us
- Hospitals and centres
- Patients and visitors
- Join our team
- Get involved
- Clinician resources
- Refer your patient
Princess Alexandra Hospital (PAH) has found a screening App could improve the clinical management of head and neck cancer patients, providing an efficient and effective alternative to additional clinical appointments.
The joint study tested the effectiveness of the ScreenIT App to assess swallowing, nutrition and distress in head and neck cancer patients undergoing chemotherapy and/or radiotherapy.
Computerised screening was found to be consistently more sensitive to patient-reported concerns and distress, and could revolutionise the way patient needs are managed. The study found patients tend to be more honest by identifying a greater number of symptoms and rating them as more severe when using ScreenIT compared to clinicians.
The web-based platform connects patients and their family to our allied health team for additional care from the right professional at the right time during their cancer treatment.
ScreenIT yields all data in five minutes which is timely and efficient for follow-up by our clinicians and also reduces unnecessary appointments allowing patients to spend more time with family or at work, rather than in hospital.
ScreenIT has already seen a 25% drop in unnecessary clinical appointments for patients undergoing cancer treatment, and has saved almost $200,000 through cost efficiencies in one year.
ScreenIT is one of 16 finalists for the 2017 eAward of the Year—the People’s Choice Award.
This joint study was conducted by researchers and clinicians at PAH, the University of Queensland, Griffith University, and funded by Cancer Council Queensland. The PA Research Foundation is now funding the implementation of this project at PAH.
The aim is to address the physical, emotional and practical needs of our patients as quickly as possible during treatment to achieve the best quality of life following this challenging diagnosis.